Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease
2003538 citationsVolker Diehl, Jeremy Franklin et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of E. Dühmke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Dühmke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Dühmke more than expected).
This network shows the impact of papers produced by E. Dühmke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Dühmke. The network helps show where E. Dühmke may publish in the future.
Co-authorship network of co-authors of E. Dühmke
This figure shows the co-authorship network connecting the top 25 collaborators of E. Dühmke.
A scholar is included among the top collaborators of E. Dühmke based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E. Dühmke. E. Dühmke is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
7 of 7 papers shown
1.
König, Andreas, Johannes Rieber, Florian Krötz, et al.. (2004). Impact of barotrauma on acute and late angiographic and clinical outcomes following angioplasty and beta-irradiation of coronary in-stent restenotic lesions.. PubMed. 16(1). 14–9.1 indexed citations
2.
Diehl, Volker, Jeremy Franklin, Michael Pfreundschuh, et al.. (2003). Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease. New England Journal of Medicine. 348(24). 2386–2395.538 indexed citations breakdown →
Fischer, G., et al.. (1994). Use of surface markers for MR radiotherapy planning.. PubMed. 170(3). 169–73.
5.
Matthaei, D., U Rühl, Normann Willich, et al.. (1993). [A comparative consideration of para-aortic fields within the framework of the German Hodgkin's Disease Study].. PubMed. 169(10). 590–4.1 indexed citations
Dühmke, E.. (1976). [Clinical relevance of histological differentiation of malignant lymphomas according to the "Kiel classification". A retrospective study of correlations in 228 cases from Schleswig-Holstein].. PubMed. 152(2). 129–39.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.